Literature DB >> 33737655

The influence of antibiotics on transitory resistome during gut colonization with CTX-M-15 and OXA-162 producing Klebsiella pneumoniae ST15.

Balázs Stercz1, Ferenc B Farkas1, Ákos Tóth2, Márió Gajdács1,3, Judit Domokos1, Viola Horváth4,5, Eszter Ostorházi1, Nóra Makra1, Béla Kocsis1, János Juhász6, Balázs Ligeti6, Sándor Pongor6, Dóra Szabó7.   

Abstract

Great efforts have been made to limit the transmission of carbapenemase-producing Enterobacteriaceae (CPE), however, the intestinal reservoir of these strains and its modulation by various antibiotics remain largely unexplored. Our aim was to assess the effects of antibiotic administration (ampicillin, ceftazidime, ciprofloxacin) on the establishment and elimination of intestinal colonization with a CTX-M-15 ESBL and OXA-162 carbapenemase producing Klebsiella pneumoniae ST15 (KP5825) in a murine (C57BL/6 male mice) model. Whole genome sequencing of KP5825 strain was performed on an Illumina MiSeq platform. Conjugation assays were carried out by broth mating method. In colonization experiments, 5 × 106 CFU of KP5825 was administered to the animals by orogastric gavage, and antibiotics were administered in their drinking water for two weeks and were changed every day. The gut colonization rates with KP5825 were assessed by cultivation and qPCR. In each of the stool samples, the gene copy number of blaOXA-162 and blaCTX-M-15 were determined by qPCR. Antibiotic concentrations in the stool were determined by high pressure liquid chromatography and a bioanalytical method. The KP5825 contained four different plasmid replicon types, namely IncFII(K), IncL, IncFIB and ColpVC. IncL (containing the blaOXA-162 resistance gene within a Tn1991.2 genetic element) and IncFII(K) (containing the blaCTX-M-15 resistance gene) plasmids were successfully conjugated. During ampicillin and ceftazidime treatments, colonization rate of KP5825 increased, while, ciprofloxacin treatments in both concentrations (0.1 g/L and 0.5 g/L) led to significantly decreased colonization rates. The gene copy number blaOXA-162 correlated with K. pneumoniae in vivo, while a major elevation was observed in the copy number of blaCTX-M-15 from the first day to the fifteenth day in the 0.5 g/L dose ceftazidime treatment group. Our results demonstrate that commonly used antibiotics may have diverse impacts on the colonization rates of intestinally-carried CPE, in addition to affecting the gene copy number of their resistance genes, thus facilitating their stable persistance and dissemination.

Entities:  

Year:  2021        PMID: 33737655     DOI: 10.1038/s41598-021-85766-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  35 in total

1.  Emergence of OXA-48-type carbapenemase-producing Enterobacteriaceae in German hospitals.

Authors:  Yvonne Pfeifer; Kathrin Schlatterer; Elisabeth Engelmann; Reinhold A Schiller; Hans Reiner Frangenberg; Doris Stiewe; Martin Holfelder; Wolfgang Witte; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

2.  Derepressed transfer properties leading to the efficient spread of the plasmid encoding carbapenemase OXA-48.

Authors:  Anaïs Potron; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

Review 3.  Incidence of Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella Infections in the United States: A Systematic Literature Review.

Authors:  Jennifer McDanel; Marin Schweizer; Victoria Crabb; Richard Nelson; Matthew Samore; Karim Khader; Amy E Blevins; Daniel Diekema; Hsiu-Yin Chiang; Rajeshwari Nair; Eli Perencevich
Journal:  Infect Control Hosp Epidemiol       Date:  2017-07-31       Impact factor: 3.254

Review 4.  Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options.

Authors:  Gisele Peirano; Johann D D Pitout
Journal:  Drugs       Date:  2019-09       Impact factor: 9.546

Review 5.  The Global Ascendency of OXA-48-Type Carbapenemases.

Authors:  Johann D D Pitout; Gisele Peirano; Marleen M Kock; Kathy-Anne Strydom; Yasufumi Matsumura
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

6.  Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study.

Authors:  Hajo Grundmann; Corinna Glasner; Barbara Albiger; David M Aanensen; Chris T Tomlinson; Arjana Tambić Andrasević; Rafael Cantón; Yehuda Carmeli; Alexander W Friedrich; Christian G Giske; Youri Glupczynski; Marek Gniadkowski; David M Livermore; Patrice Nordmann; Laurent Poirel; Gian M Rossolini; Harald Seifert; Alkiviadis Vatopoulos; Timothy Walsh; Neil Woodford; Dominique L Monnet
Journal:  Lancet Infect Dis       Date:  2016-11-18       Impact factor: 25.071

Review 7.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 8.  The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide.

Authors:  P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2014-09       Impact factor: 8.067

9.  In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015.

Authors:  Krystyna M Kazmierczak; Patricia A Bradford; Gregory G Stone; Boudewijn L M de Jonge; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 10.  The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world.

Authors:  Yohei Doi; Alina Iovleva; Robert A Bonomo
Journal:  J Travel Med       Date:  2017-04-01       Impact factor: 8.490

View more
  4 in total

1.  Changes in Fecal Carriage of Extended-Spectrum β-Lactamase Producing Enterobacterales in Dutch Veal Calves by Clonal Spread of Klebsiella pneumoniae.

Authors:  Teresita D J Bello Gonzalez; Arie Kant; Quillan Dijkstra; Francesca Marcato; Kees van Reenen; Kees T Veldman; Michael S M Brouwer
Journal:  Front Microbiol       Date:  2022-06-23       Impact factor: 6.064

2.  Prevalence and antimicrobial susceptibility of CTX-M-type-producing Escherichia coli from a wildlife zoo in China.

Authors:  Ziyue Zeng; Jie Yang; Jinrong Gu; Zhihong Liu; Jufang Hu; Xiangyong Li; Xiaojun Chen; Zhiliang Sun; Jiyun Li
Journal:  Vet Med Sci       Date:  2022-02-19

3.  Co-Occurrence of β-Lactam and Aminoglycoside Resistance Determinants among Clinical and Environmental Isolates of Klebsiella pneumoniae and Escherichia coli: A Genomic Approach.

Authors:  Hisham N Altayb; Hana S Elbadawi; Faisal A Alzahrani; Othman Baothman; Imran Kazmi; Muhammad Shahid Nadeem; Salman Hosawi; Kamel Chaieb
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-17

4.  Colonization Dynamics of Multidrug-Resistant Klebsiella pneumoniae Are Dictated by Microbiota-Cluster Group Behavior over Individual Antibiotic Susceptibility: A Metataxonomic Analysis.

Authors:  János Juhász; Balázs Ligeti; Márió Gajdács; Nóra Makra; Eszter Ostorházi; Ferenc Balázs Farkas; Balázs Stercz; Ákos Tóth; Judit Domokos; Sándor Pongor; Dóra Szabó
Journal:  Antibiotics (Basel)       Date:  2021-03-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.